Laboratory Medicine ›› 2026, Vol. 41 ›› Issue (9): 907-912.DOI: 10.3969/j.issn.1673-8640.2026.09.014
Previous Articles Next Articles
WANG Shuang, MENG Qiang, LIU Shiyao, FU Yang, JIANG Hong(
)
Received:2024-05-18
Revised:2026-01-04
Online:2026-09-30
Published:2026-09-29
CLC Number:
WANG Shuang, MENG Qiang, LIU Shiyao, FU Yang, JIANG Hong. Analysis of dynamic trends in peripheral blood cell parameters among apparently healthy adults in Chengdu[J]. Laboratory Medicine, 2026, 41(9): 907-912.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2026.09.014
| 时间 | 例数 | 性别 | 年龄 | 职业 | 分布 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 18~40岁 | 41~60岁 | >60岁 | 离退休 人员 | 专业技术 人员 | 工人 | 农民 | 其他 | 成都常住 居民 | 其他 | |||||
| 2011年 | 13 474 | 7 421 | 6 053 | 3 776 | 7 526 | 2 172 | 4 419 | 7 195 | 903 | 472 | 485 | 12 625 | 849 | |||
| 2016年 | 97 936 | 54 223 | 43 713 | 41 120 | 44 783 | 12 033 | 36 531 | 50 143 | 5 680 | 2 742 | 2 840 | 92 255 | 5 681 | |||
| 2021年 | 161 819 | 86 937 | 74 882 | 74 434 | 68 039 | 19 346 | 55 667 | 91 751 | 5 178 | 1 780 | 7 443 | 153 404 | 8 415 | |||
| 时间 | 例数 | 性别 | 年龄 | 职业 | 分布 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 18~40岁 | 41~60岁 | >60岁 | 离退休 人员 | 专业技术 人员 | 工人 | 农民 | 其他 | 成都常住 居民 | 其他 | |||||
| 2011年 | 13 474 | 7 421 | 6 053 | 3 776 | 7 526 | 2 172 | 4 419 | 7 195 | 903 | 472 | 485 | 12 625 | 849 | |||
| 2016年 | 97 936 | 54 223 | 43 713 | 41 120 | 44 783 | 12 033 | 36 531 | 50 143 | 5 680 | 2 742 | 2 840 | 92 255 | 5 681 | |||
| 2021年 | 161 819 | 86 937 | 74 882 | 74 434 | 68 039 | 19 346 | 55 667 | 91 751 | 5 178 | 1 780 | 7 443 | 153 404 | 8 415 | |||
| 项目 | 例数 | RBC计数/(×1012L-1) | Hb/(g·L-1) | PLT计数/ (×109L-1) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 男 | 女 | |||||||
| 整体 | 273 229 | 5.15±0.46 | 4.51±0.39 | 156.13±11.45 | 133.43±11.35 | 209.57±59.75 | ||||
| 2011年 | 13 474 | 5.08±0.45 | 4.48±0.39 | 155.23±11.96 | 132.13±11.22 | 171.55±53.82 | ||||
| 2016年 | 97 936 | 5.2±0.46* | 4.57±0.39* | 157.02±11.43* | 134.48±11.12* | 200.49±59.5* | ||||
| 2021年 | 161 819 | 5.13±0.46*# | 4.47±0.39# | 155.66±11.38*# | 132.92±11.44*# | 218.23±58.3*# | ||||
| F值 | 523.754 | 866.937 | 263.378 | 302.933 | 5 793.692 | |||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |||||
| 项目 | WBC计数/(×109L-1) | NEUT#/(×109L-1) | LYMPH#/(×109L-1) | MO#/(×109L-1) | ||||||
| 整体 | 6.01±1.54 | 3.53±1.19 | 1.91±0.59 | 0.39±0.13 | ||||||
| 2011年 | 6.04±1.58 | 3.64±1.23 | 1.91±0.58 | 0.30±0.12 | ||||||
| 2016年 | 6.16±1.58* | 3.67±1.23 | 1.95±0.59* | 0.36±0.13* | ||||||
| 2021年 | 5.90±1.51*# | 3.43±1.14*# | 1.87±0.58*# | 0.41±0.13*# | ||||||
| F值 | 861.101 | 1 293.806 | 500.761 | 7 243.133 | ||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||
| 项目 | 例数 | RBC计数/(×1012L-1) | Hb/(g·L-1) | PLT计数/ (×109L-1) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 男 | 女 | |||||||
| 整体 | 273 229 | 5.15±0.46 | 4.51±0.39 | 156.13±11.45 | 133.43±11.35 | 209.57±59.75 | ||||
| 2011年 | 13 474 | 5.08±0.45 | 4.48±0.39 | 155.23±11.96 | 132.13±11.22 | 171.55±53.82 | ||||
| 2016年 | 97 936 | 5.2±0.46* | 4.57±0.39* | 157.02±11.43* | 134.48±11.12* | 200.49±59.5* | ||||
| 2021年 | 161 819 | 5.13±0.46*# | 4.47±0.39# | 155.66±11.38*# | 132.92±11.44*# | 218.23±58.3*# | ||||
| F值 | 523.754 | 866.937 | 263.378 | 302.933 | 5 793.692 | |||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |||||
| 项目 | WBC计数/(×109L-1) | NEUT#/(×109L-1) | LYMPH#/(×109L-1) | MO#/(×109L-1) | ||||||
| 整体 | 6.01±1.54 | 3.53±1.19 | 1.91±0.59 | 0.39±0.13 | ||||||
| 2011年 | 6.04±1.58 | 3.64±1.23 | 1.91±0.58 | 0.30±0.12 | ||||||
| 2016年 | 6.16±1.58* | 3.67±1.23 | 1.95±0.59* | 0.36±0.13* | ||||||
| 2021年 | 5.90±1.51*# | 3.43±1.14*# | 1.87±0.58*# | 0.41±0.13*# | ||||||
| F值 | 861.101 | 1 293.806 | 500.761 | 7 243.133 | ||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||
| 时间 | RBC计数/(×1012L-1) | Hb/(g·L-1) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18~40岁 | 41~60岁 | >60岁 | 18~40岁 | 41~60岁 | >60岁 | ||||||||||||
| 2011年 | 4.86±0.54 | 4.83±0.50 | 4.66±0.51 | 145.57±16.59 | 145.90±16.37 | 139.99±14.93 | |||||||||||
| 2016年 | 4.98±0.55* | 4.91±0.52* | 4.76±0.52* | 147.40±16.17* | 147.14±16.01* | 144.22±14.29* | |||||||||||
| 2021年 | 4.87±0.56# | 4.82±0.52*# | 4.67±0.51*# | 144.95±16.61*# | 145.91±15.89# | 143.11±14.45# | |||||||||||
| F值 | 569.806 | 404.351 | 100.554 | 295.053 | 104.865 | 82.968 | |||||||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |||||||||||
| 时间 | PLT计数/(×109L-1) | WBC计数/(×109L-1) | |||||||||||||||
| 18~40岁 | 41~60岁 | >60岁 | 18~40岁 | 41~60岁 | >60岁 | ||||||||||||
| 2011年 | 176.13±53.22 | 169.66±52.64 | 170.12±58.30 | 6.02±1.58 | 6.01±1.56 | 6.16±1.63 | |||||||||||
| 2016年 | 211.83±57.97* | 195.04±59.27* | 182.06±58.07* | 6.26±1.55* | 6.06±1.58* | 6.21±1.70 | |||||||||||
| 2021年 | 230.57±55.88*# | 211.86±58.00*# | 193.16±56.81*# | 5.94±1.47*# | 5.83±1.53*# | 6.03±1.57*# | |||||||||||
| F值 | 2 761.697 | 2 445.446 | 247.937 | 574.27 | 334.511 | 44.509 | |||||||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |||||||||||
| 时间 | NEUT#/(×109L-1) | LYMPH#/(×109L-1) | MO#/(×109L-1) | ||||||||||||||
| 18~40岁 | 41~60岁 | >60岁 | 18~40岁 | 41~60岁 | >60岁 | 18~40岁 | 41~60岁 | >60岁 | |||||||||
| 2011年 | 3.65±1.24 | 3.64±1.22 | 3.67±1.25 | 1.90±0.56 | 1.89±0.56 | 1.97±0.66 | 0.31±0.11 | 0.31±0.12 | 0.32±0.12 | ||||||||
| 2016年 | 3.71±1.24* | 3.63±1.22 | 3.68±1.26 | 2.00±0.54* | 1.90±0.57 | 1.94±0.80* | 0.37±0.12* | 0.36±0.13* | 0.40±0.14* | ||||||||
| 2021年 | 3.45±1.14*# | 3.40±1.14*# | 3.50±1.16*# | 1.91±0.53# | 1.83±0.60*# | 1.88±0.70*# | 0.41±0.13*# | 0.41±0.13*# | 0.45±0.14*# | ||||||||
| F值 | 706.201 | 551.104 | 89.235 | 393.973 | 217.466 | 32.379 | 2 416.352 | 3 694.638 | 1 241.769 | ||||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||||
| 时间 | RBC计数/(×1012L-1) | Hb/(g·L-1) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18~40岁 | 41~60岁 | >60岁 | 18~40岁 | 41~60岁 | >60岁 | ||||||||||||
| 2011年 | 4.86±0.54 | 4.83±0.50 | 4.66±0.51 | 145.57±16.59 | 145.90±16.37 | 139.99±14.93 | |||||||||||
| 2016年 | 4.98±0.55* | 4.91±0.52* | 4.76±0.52* | 147.40±16.17* | 147.14±16.01* | 144.22±14.29* | |||||||||||
| 2021年 | 4.87±0.56# | 4.82±0.52*# | 4.67±0.51*# | 144.95±16.61*# | 145.91±15.89# | 143.11±14.45# | |||||||||||
| F值 | 569.806 | 404.351 | 100.554 | 295.053 | 104.865 | 82.968 | |||||||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |||||||||||
| 时间 | PLT计数/(×109L-1) | WBC计数/(×109L-1) | |||||||||||||||
| 18~40岁 | 41~60岁 | >60岁 | 18~40岁 | 41~60岁 | >60岁 | ||||||||||||
| 2011年 | 176.13±53.22 | 169.66±52.64 | 170.12±58.30 | 6.02±1.58 | 6.01±1.56 | 6.16±1.63 | |||||||||||
| 2016年 | 211.83±57.97* | 195.04±59.27* | 182.06±58.07* | 6.26±1.55* | 6.06±1.58* | 6.21±1.70 | |||||||||||
| 2021年 | 230.57±55.88*# | 211.86±58.00*# | 193.16±56.81*# | 5.94±1.47*# | 5.83±1.53*# | 6.03±1.57*# | |||||||||||
| F值 | 2 761.697 | 2 445.446 | 247.937 | 574.27 | 334.511 | 44.509 | |||||||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |||||||||||
| 时间 | NEUT#/(×109L-1) | LYMPH#/(×109L-1) | MO#/(×109L-1) | ||||||||||||||
| 18~40岁 | 41~60岁 | >60岁 | 18~40岁 | 41~60岁 | >60岁 | 18~40岁 | 41~60岁 | >60岁 | |||||||||
| 2011年 | 3.65±1.24 | 3.64±1.22 | 3.67±1.25 | 1.90±0.56 | 1.89±0.56 | 1.97±0.66 | 0.31±0.11 | 0.31±0.12 | 0.32±0.12 | ||||||||
| 2016年 | 3.71±1.24* | 3.63±1.22 | 3.68±1.26 | 2.00±0.54* | 1.90±0.57 | 1.94±0.80* | 0.37±0.12* | 0.36±0.13* | 0.40±0.14* | ||||||||
| 2021年 | 3.45±1.14*# | 3.40±1.14*# | 3.50±1.16*# | 1.91±0.53# | 1.83±0.60*# | 1.88±0.70*# | 0.41±0.13*# | 0.41±0.13*# | 0.45±0.14*# | ||||||||
| F值 | 706.201 | 551.104 | 89.235 | 393.973 | 217.466 | 32.379 | 2 416.352 | 3 694.638 | 1 241.769 | ||||||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||||
| 项目 | RBC计数 | Hb | PLT计数 | WBC计数 | NEUT# | LYMPH# | MO# | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 男 | 女 | |||||||
| 2011—2016年 | 2.36 | 2.01 | 1.15 | 1.78 | 16.87 | 1.99 | 0.82 | 2.09 | 20.00 | |
| 2016—2021年 | -1.35 | -2.19 | -0.87 | -1.16 | 8.85 | -4.22 | -6.54 | -4.10 | 13.89 | |
| 2011—2021年 | 0.98 | -0.22 | 0.28 | 0.60 | 27.21 | -2.32 | -5.77 | -2.09 | 36.67 | |
| 项目 | RBC计数 | Hb | PLT计数 | WBC计数 | NEUT# | LYMPH# | MO# | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 男 | 女 | |||||||
| 2011—2016年 | 2.36 | 2.01 | 1.15 | 1.78 | 16.87 | 1.99 | 0.82 | 2.09 | 20.00 | |
| 2016—2021年 | -1.35 | -2.19 | -0.87 | -1.16 | 8.85 | -4.22 | -6.54 | -4.10 | 13.89 | |
| 2011—2021年 | 0.98 | -0.22 | 0.28 | 0.60 | 27.21 | -2.32 | -5.77 | -2.09 | 36.67 | |
| [1] |
Lee S T, Chen P Y, Lin J W, et al, Complete blood cell detection and counting based on deep neural networks[J]. Applied Sciences, 2022, 12(16):2-16.
DOI URL |
| [2] |
Masuch A, Budde K, Kastenmüller G, et al. Metabolic signature associated with parameters of the complete blood count in apparently healthy individuals[J]. J Cell Mol Med, 2019, 23(8):5144-5153.
DOI PMID |
| [3] |
Lee E J, Kim M, Lee E, et al. A comparison of complete blood count reference intervals in healthy elderly vs. younger Korean adults:a large population study[J]. Clin Chem Lab Med, 2019, 57(5):716-729.
DOI URL |
| [4] |
Qiao R, Yang S, Yao B, et al. Complete blood count reference intervals and age- and sex-related trends of North China Han population[J]. Clin Chem Lab Med, 2014, 52(7):1025-1032.
DOI PMID |
| [5] |
Takami A, Watanabe S, Yamamoto Y, et al. Reference intervals of red blood cell parameters and platelet count for healthy adults in Japan[J]. Int J Hematol, 2021, 114(3):373-380.
DOI PMID |
| [6] | 张梅, 刘娜, 吴妍, 等. 衡水地区健康成人血细胞参数的参考区间的调查[J]. 现代预防医学, 2015, 42(4):705-707. |
| [7] |
Hong J, Min Z, Bai-shen P, et al. Investigation on reference intervals and regional differences of platelet indices in healthy Chinese Han adults[J]. J Clin Lab Anal, 2015, 29(1):21-27.
DOI PMID |
| [8] | WS/T 402-2012 临床实验室检验项目参考区间的制定[S]. 2012. |
| [9] |
Hung S C, Yang C C, Liu C F, et al. The association pattern between ambient temperature change and leukocyte counts[J]. Int J Environ Res Public Health, 2021, 18(13):6971.
DOI URL |
| [10] |
Niu Q, Zhang R, Zhao M, et al. Differences in platelet indices between healthy Han population and Tibetans in China[J]. PLoS One, 2013, 8(6):e67203.
DOI URL |
| [11] | Rohrig G. White blood cell counts,CRP,GGT and LDH in the elderly German population[J]. J Lab Med, 2019(2):57-65. |
| [12] |
Wang J, Zhang F, Jiang F, et al. Distribution and reference interval establishment of neutral-to-lymphocyte ratio (NLR),lymphocyte-to-monocyte ratio (LMR),and platelet-to-lymphocyte ratio (PLR) in Chinese healthy adults[J]. J Clin Lab Anal, 2021, 35(9):e23935.
DOI URL |
| [13] | WS/T 406-2012 临床血液学检验常规项目分析质量要求[S]. 2012. |
| [14] | 江虹, 陈思, 蔡力力, 等. 中国老年健康人群血常规检测结果多中心调查[J]. 中华检验医学杂志, 2021, 44(1):25-31. |
| [15] | 刘艳婷, 曹丹, 陈姝, 等. 四川遂宁地区表观健康老年人群血细胞分析参考区间的适宜性验证[J]. 标记免疫分析与临床, 2022, 29(1):123-127. |
| [16] |
Thompson P L, Nidorf S M. Anti-inflammatory therapy with canakinumab for atherosclerotic disease:lessons from the CANTOS trial[J]. J Thorac Dis, 2018, 10(2):695-698.
DOI PMID |
| [17] |
Gasparyan A Y, Stavropoulos-kalinoglou A, Mikhailidis D P, et al. Platelet function in rheumatoid arthritis:arthritic and cardiovascular implications[J]. Rheumatol Int, 2011, 31(2):153-164.
DOI PMID |
| [18] |
Brook R D, Sun Z, Brook J R, et al. Extreme air pollution conditions adversely affect blood pressure and insulin resistance:the air pollution and cardiometabolic disease study[J]. Hypertension, 2016, 67(1):77-85.
DOI URL |
| [19] | Netea M G, Joosten L A, Latz E, et al. Trained immunity:a program of innate immune memory in health and disease[J]. Science, 2016, 352(6284):aaf1098. |
| [20] |
Maslowski K M, Vieira A T, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43[J]. Nature, 2009, 461(7268):1282-1286.
DOI |
| [21] |
Heidt T, Sager H B, Courties G, et al. Chronic variable stress activates hematopoietic stem cells[J]. Nat Med, 2014, 20(7):754-758.
DOI PMID |
| [22] |
Sandfeld-paulsen B, Pedersen L Ø, Damgaard T K, et al. Reference intervals for platelet large cell ratio,platelet distribution width,plateletcrit and standard haematological parameters determined on the Sysmex XN-10 in a cohort of 30 917 Danish blood donors[J]. Scand J Clin Lab Invest, 2022, 82(6):439-445.
DOI URL |
| [23] |
Schupp T, Weidner K, Rusnak J, et al. Diagnostic and prognostic role of platelets in patients with sepsis and septic shock[J]. Platelets, 2023, 34(1):2131753.
DOI URL |
| [24] |
Kim J M, Choi J S. The analysis of neutrophil to lymphocyte ratio (NLR),lymphocyte to monocyte ratio (LMR),and platelet to lymphocyte ratio (PLR) in patients with adenoidectomy and tonsillectomy[J]. J Clin Med, 2024, 13(18):5457.
DOI URL |
| [25] |
Cursi L, Lancella L, Mariani F, et al. Monocyte-to-lymphocyte,neutrophil-to-lymphocyte and neutrophil-to-monocyte plus lymphocyte ratios in children with active tuberculosis:a multicentre study[J]. Acta Paediatr, 2023, 112(11):2418-2425.
DOI URL |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||